Go to content
To the homepage of Medicines Evaluation Board
You are here: Home Topics MEB policy documents Documents MEB 27: MEB commentary on the ‘Guideline on Summary of Product Characteristics’

MEB 27: MEB commentary on the ‘Guideline on Summary of Product Characteristics’

This document serves as a commentary on the ‘Guideline on Summary of Product Characteristics’.

Download this policy document in English or in Dutch.

Download "MEB 27: Toelichting van het College op de Guideline on Summary of Product Characteristics" 1/2

PDF document | 13 pages | 744 kB

Policy document | 23-08-2017

Download "Dutch version: MEB 27: Toelichting van het College op de ‘Guideline on Summary of Product Characteristics’" 2/2

PDF document | 13 pages | 415 kB

Policy document | 23-08-2017

See also

  • Summary of product characteristics (SmPC)

Belongs to

  • Marketing authorisation – medicines for human use

Share this page

  • Twitter
  • Facebook
  • LinkedIn
Good medicines used better.

Service

  • Contact
  • Working at the MEB
  • Sitemap
  • Help
  • Archive
  • Subscribe

About this site

  • Copyright
  • Privacy
  • Cookies
  • Accessibility
  • Report vulnerability
  • Nederlands